220 related articles for article (PubMed ID: 33420490)
41. Differential Src family kinase activity requirements for CD3 zeta phosphorylation/ZAP70 recruitment and CD3 epsilon phosphorylation.
Lysechko TL; Ostergaard HL
J Immunol; 2005 Jun; 174(12):7807-14. PubMed ID: 15944285
[TBL] [Abstract][Full Text] [Related]
42. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
Krystal GW; DeBerry CS; Linnekin D; Litz J
Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
[TBL] [Abstract][Full Text] [Related]
43. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
Yu XZ; Levin SD; Madrenas J; Anasetti C
J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
[TBL] [Abstract][Full Text] [Related]
44. The kinase-dependent function of Lck in T-cell activation requires an intact site for tyrosine autophosphorylation.
Xu H; Littman DR
Ann N Y Acad Sci; 1995 Sep; 766():99-116. PubMed ID: 7486706
[TBL] [Abstract][Full Text] [Related]
45. Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny.
Longo NS; Wang X; Wildin RS; Abraham KM
Mol Immunol; 1999; 36(15-16):979-92. PubMed ID: 10698302
[TBL] [Abstract][Full Text] [Related]
46. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity.
D'Oro U; Sakaguchi K; Appella E; Ashwell JD
Mol Cell Biol; 1996 Sep; 16(9):4996-5003. PubMed ID: 8756658
[TBL] [Abstract][Full Text] [Related]
47. The role of competing mechanisms on Lck regulation.
Bozso SJ; Kang JJH; Nagendran J
Immunol Res; 2020 Oct; 68(5):289-295. PubMed ID: 32794043
[TBL] [Abstract][Full Text] [Related]
48. alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases.
van Oers NS; Lowin-Kropf B; Finlay D; Connolly K; Weiss A
Immunity; 1996 Nov; 5(5):429-36. PubMed ID: 8934570
[TBL] [Abstract][Full Text] [Related]
49. Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8
Li M; Yang Y; Wei J; Cun X; Lu Z; Qiu Y; Zhang Z; He Q
Nanomedicine; 2018 Nov; 14(8):2541-2550. PubMed ID: 30193815
[TBL] [Abstract][Full Text] [Related]
50. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels.
al-Ramadi BK; Nakamura T; Leitenberg D; Bothwell AL
J Immunol; 1996 Dec; 157(11):4751-61. PubMed ID: 8943376
[TBL] [Abstract][Full Text] [Related]
51. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
52. Association between mitogen-activated protein kinase and the zeta chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking.
August A; Dupont B
J Biol Chem; 1996 Apr; 271(17):10054-9. PubMed ID: 8626561
[TBL] [Abstract][Full Text] [Related]
53. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn.
Löwenberg M; Tuynman J; Bilderbeek J; Gaber T; Buttgereit F; van Deventer S; Peppelenbosch M; Hommes D
Blood; 2005 Sep; 106(5):1703-10. PubMed ID: 15899916
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 4 inhibits IL-2-induced proliferation of a human T-leukemia cell line without interfering with p56-LCK kinase activation.
Torigoe T; O'Connor R; Fagard R; Fischer S; Santoli D; Reed JC
Cytokine; 1992 Sep; 4(5):369-76. PubMed ID: 1420998
[TBL] [Abstract][Full Text] [Related]
55. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
[TBL] [Abstract][Full Text] [Related]
56. Anti-VEGF Treatment Enhances CD8
de Almeida PE; Mak J; Hernandez G; Jesudason R; Herault A; Javinal V; Borneo J; Kim JM; Walsh KB
Cancer Immunol Res; 2020 Jun; 8(6):806-818. PubMed ID: 32238381
[TBL] [Abstract][Full Text] [Related]
57. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules.
Wiest DL; Yuan L; Jefferson J; Benveniste P; Tsokos M; Klausner RD; Glimcher LH; Samelson LE; Singer A
J Exp Med; 1993 Nov; 178(5):1701-12. PubMed ID: 8228817
[TBL] [Abstract][Full Text] [Related]
58. Requirement for p56lck tyrosine kinase activation in T cell receptor-mediated thymic selection.
Hashimoto K; Sohn SJ; Levin SD; Tada T; Perlmutter RM; Nakayama T
J Exp Med; 1996 Sep; 184(3):931-43. PubMed ID: 9064353
[TBL] [Abstract][Full Text] [Related]
59. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
60. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.
Gibson S; Truitt K; Lu Y; Lapushin R; Khan H; Imboden JB; Mills GB
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1123-8. PubMed ID: 9494076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
